March 23, 2026
After working at Weill Cornell Medicine for more than 20 years, Jennifer Moon never imagined she would become a patient herself.
March 6, 2026
More individuals are surviving cancer than ever before. The overall five-year survival rate across all cancers in the United States has reached an historic 70%, translating to nearly 19 million cancer survivors nationwide, including more than four million breast cancer survivors.1
To help breast cancer survivors thrive long after completion of treatment for their disease, in 2020, Weill Cornell Medicine and NewYork-Presbyterian Hospital launched the Iris Cantor Breast Cancer Survivorship... Read More
February 27, 2026
Liquid biopsies are changing how doctors learn about cancer. Instead of taking a tissue sample from a tumor, a liquid biopsy uses a simple blood draw to gather clues about what’s happening inside the body.
January 22, 2026
Weill Cornell Medicine physicians have been recognized among the finest in the nation as part of Castle Connolly 2026 Top Doctors.
November 21, 2025
A liquid biopsy is a blood test that looks for cancer cells or genetic material, such as DNA, that are shed into the bloodstream in patients with cancer. In this episode of CancerCast, Dr. Massimo Cristofanilli and Dr. Manish Shah explore how liquid biopsies unlock real-time insights into cancer evolution through molecular diagnostics, painting a more comprehensive and holistic picture of what’s going on with cancer inside the body, and often much earlier than other imaging tools. By analyzing... Read More
